Figure 2.
Relative risk of mortality from all causes in trials of angiotensin converting enzyme inhibitors compared with placebo in relation to underlying low and high mortality risk of trial subjects
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.